Shed HER2 extracellular domain in HER2-mediated tumor growth and in trastuzumab susceptibility.

Ghedini, Gaia C; Ciravolo, Valentina; Tortoreto, Monica; Giuffrè, Sarah; Bianchi, Francesca; Campiglio, Manuela; Mortarino, Mimosa; Figini, Mariangela; Coliva, Angela; Carcangiu, Maria L; Zambetti, Milvia; Piazza, Tiziana; Ferrini, Silvano; Ménard, Sylvie; Tagliabue, Elda; Pupa, Serenella M

Ghedini, Gaia C; Ciravolo, Valentina; Tortoreto, Monica; Giuffrè, Sarah; Bianchi, Francesca; Campiglio, Manuela; Mortarino, Mimosa; Figini, Mariangela; Coliva, Angela; Carcangiu, Maria L; Zambetti, Milvia; Piazza, Tiziana; Ferrini, Silvano; Ménard, Sylvie; Tagliabue, Elda; Pupa, Serenella M.

Affiliation

Ghedini GC; Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

J Cell Physiol ; 225(1): 256-65, 2010 Oct.

Article in En | MEDLINE | ID: mdl-20506359

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Receptor, ErbB-2 / Antibodies, Monoclonal / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: J Cell Physiol Year: 2010 Document type: Article Affiliation country: Italia

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google